Stereotactic Body Radiotherapy Combined with Targeted Therapy in Oligoprogressive or Primary Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer

2020 ◽  
Vol 108 (3) ◽  
pp. e178-e179
Author(s):  
A. Rishi ◽  
S. Sun ◽  
A.M. Karimi ◽  
A.J. Sim ◽  
J. Gray ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Epidermal Growth Factor Receptor ◽  
Targeted Therapy ◽  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Stereotactic Body Radiotherapy ◽  
Growth Factor Receptor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Epidermal Growth

scholarly journals Epidermal Growth Factor Receptor Expression and Resistance Patterns to Targeted Therapy in Non-Small Cell Lung Cancer: A Review

Cells ◽  
2021 ◽  
Vol 10 (5) ◽  
pp. 1206
Author(s):  
Emma-Anne Karlsen ◽  
Sam Kahler ◽  
Joan Tefay ◽  
Shannon R. Joseph ◽  
Fiona Simpson
Keyword(s):  
Lung Cancer ◽  
Epidermal Growth Factor Receptor ◽  
Targeted Therapy ◽  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Growth Factor Receptor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Resistance Patterns ◽  
Epidermal Growth

Globally, lung cancer is the leading cause of cancer-related death. The majority of non-small cell lung cancer (NSCLC) tumours express epidermal growth factor receptor (EGFR), which allows for precise and targeted therapy in these patients. The dysregulation of EGFR in solid epithelial cancers has two distinct mechanisms: either a kinase-activating mutation in EGFR (EGFR-mutant) and/or an overexpression of wild-type EGFR (wt-EGFR). The underlying mechanism of EGFR dysregulation influences the efficacy of anti-EGFR therapy as well as the nature of resistance patterns and secondary mutations. This review will critically analyse the mechanisms of EGFR expression in NSCLC, its relevance to currently approved targeted treatment options, and the complex nature of secondary mutations and intrinsic and acquired resistance patterns in NSCLC.

Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC)

Lung Cancer ◽  
2003 ◽  
Vol 41 (2) ◽  
pp. 227-231 ◽  
Author(s):  
Federico Cappuzzo ◽  
Andrea Ardizzoni ◽  
Hector Soto-Parra ◽  
Cesare Gridelli ◽  
Paolo Maione ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Epidermal Growth Factor Receptor ◽  
Targeted Therapy ◽  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Brain Metastases ◽  
Growth Factor Receptor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Epidermal Growth
Sign in / Sign up

Export Citation Format

Share Document